Search

everythinglearnresearchcommunity

for

Search:↓

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Finasteride helps hair growth but stopping it causes faster hair loss.

Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.

A man's baldness improved possibly due to a medication that blocks male hormones.

Higher androgen levels are linked to more severe hair growth in hirsute women.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Herbal medicines can reduce the effectiveness of birth control pills.

Any medication can cause skin reactions, some due to allergies and others due to dosage or genetic factors.

Dutasteride is a safe and effective treatment for hair loss.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

We need better treatments for hair loss, and while test-tube methods are helpful, they can't fully replace animal tests for evaluating new hair growth treatments.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Most over-the-counter hair loss treatments lack strong evidence of effectiveness, except for minoxidil, which works but stops working if you stop using it.

Balancing testosterone may reduce COVID-19 severity.

Numerical methods help analyze alopecia drugs' properties effectively.

New methods are being developed to improve drug delivery to the brain.

Tribulus terrestris may protect the liver from drug damage.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.